pharmiweb.com today archive

Pharma services company is on expansion path

Global pharmaceutical manufacturer and developer, Penn Pharma, has today [28 February 2012] announced a £14 million investment in its South Wales UK facility to strengthen its offering for international supply and further build on the company’s established high tech manufacturing capabilities.

The investment sees the 33 year old company expand its specialist high containment facilities with a 15,000 sq ft new development and commercial manufacturing unit for tablets and capsules meeting the highest international Quality Standards. The new facility will enable the team at Penn to further build upon its established expertise in the manufacture of specialist drugs for the worldwide market.

Speaking on the announcement Chief Executive, Dr Richard Yarwood said: “We are delighted to announce this significant investment in the UK pharmaceutical manufacturing sector at a time when the established industry remodels itself and out-sourcing is on the increase.�
Read full story here